SpringerLink
Log in

Serum N-terminal pro-brain natriuretic peptide, a marker of skin thickness in systemic sclerosis?

  • Letter to the Editor
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (France)

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Choi HJ, Shin YK, Hyun JL et al (2008) The clinical significance of serum N-terminal pro-brain natriuretic peptide in systemic sclerosis patients. Clin Rheumatol 27:437–442

    Article  PubMed  Google Scholar 

  2. Subcomittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581–590

    Article  Google Scholar 

  3. Clements PJ, Meedsger TA Jr, Feghali CA (2004) Cutaneous involvement in systemic sclerosis. In: Clements PJ, Furst DE (eds) Systemic sclerosis, 2nd edn. Lippincott Williams and Wilkins, Baltimore, pp 129–150

    Google Scholar 

  4. Lip P, Wang D, Lucas J et al (2008) Atrial natriuretic peptide inhibits Transforming Growth Factor β-induces Smad signalling and myofibroblast transformation in mouse cardiac fibroblasts. Circ Res 102:185–192

    Article  Google Scholar 

  5. Goetze JP, Christoffersen C, Perko M et al (2003) Increased cardiac BNP expression associated with myocardial ischemia. FASEB J 17:1105–1107

    PubMed  CAS  Google Scholar 

  6. Casco VH, Veinot JP, Kuroski de Bold ML et al (2002) Natriuretic peptide system gene expression in human coronary arteries. J Histochem Cytochem 50:799–809

    PubMed  CAS  Google Scholar 

  7. Hopkins WE, Chen Z, Fukagawa NK et al (2004) Increased atrial and brain natriuretic peptides in adults with cyanotic congenital heart disease: enhanced understanding of the relationship between hypoxia and natriuretic peptide secretion. Circulation 109:2872–2877

    Article  PubMed  CAS  Google Scholar 

  8. Clements PJ, Hurwitz EL, Wong WK et al (2000) Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial. Arthritis Rheum 43:2445–2454

    Article  PubMed  CAS  Google Scholar 

Download references

Disclosures

None.

Author information

Authors and Affiliations

  1. Rheumatology Unit, IRCCS Humanitas Clinical Institute, University of Milan, Milan, Italy

    Nicoletta Carlo-Stella, Laura Belloli & Bianca Marasini

  2. Laboratory of Clinical Analysis, San Paolo Hospital, Milan, Italy

    Maria Luisa Biondi

Authors
  1. Nicoletta Carlo-Stella
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Laura Belloli
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Maria Luisa Biondi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Bianca Marasini
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bianca Marasini.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Carlo-Stella, N., Belloli, L., Biondi, M.L. et al. Serum N-terminal pro-brain natriuretic peptide, a marker of skin thickness in systemic sclerosis?. Clin Rheumatol 28, 241–242 (2009). https://doi.org/10.1007/s10067-008-1048-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-008-1048-0

Keywords

Search

Navigation